Table 5 Rate ratios (95% CI) for number and days of hospitalisation during three-year follow-up according to type of sarcopenia definition
Model 1 RR (95% CI) | p–value | Model 2 RR (95% CI) | p–value | Model 3 RR (95% CI) | p–value | |
|---|---|---|---|---|---|---|
Number of hospitalisations | ||||||
Sarcopenia (EWGSOP) | 1.49 (1.00–2.22) | 0.048 | 1.33 (0.95–1.87) | 0.095 | 1.31 (0.93–1.83) | 0.12 |
Probable sarcopenia (EWGSOP2) | 1.46 (1.05–2.03) | 0.024 | 1.25 (0.91–1.72) | 0.17 | 1.25 (0.91–1.72) | 0.17 |
Sarcopenia (EWGSOP2) | 1.18 (0.80–1.75) | 0.41 | 1.11 (0.79–1.55) | 0.54 | 1.10 (0.79–1.53) | 0.57 |
Sarcopenia (FNIH) | 2.10 (1.33–3.33) | 0.002 | 1.78 (1.07–2.97) | 0.026 | 1.75 (1.10–2.81) | 0.019 |
Days of hospitalisation | ||||||
Sarcopenia (EWGSOP) | 1.63 (0.92–2.90) | 0.097 | 1.38 (0.83–2.32) | 0.22 | 1.36 (0.81–2.29) | 0.24 |
Probable sarcopenia (EWGSOP2) | 2.90 (1.86–4.52) | < 0.001 | 2.20 (1.42–3.40) | < 0.001 | 2.12 (1.36–3.30) | 0.001 |
Sarcopenia (EWGSOP2) | 1.03 (0.60–1.76) | 0.91 | 1.00 (0.61–1.62) | 0.99 | 1.00 (0.62–1.63) | 0.99 |
Sarcopenia (FNIH) | 2.59 (1.34–5.03) | 0.005 | 1.89 (0.97–3.67) | 0.062 | 1.80 (0.93–3.47) | 0.079 |